Update on glycopeptide resistance in enterococci
- 31 December 1990
- journal article
- research article
- Published by Elsevier in Antimicrobic Newsletter
- Vol. 7 (11-12) , 81-86
- https://doi.org/10.1016/0738-1751(90)90027-a
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic optionsJournal of Antimicrobial Chemotherapy, 1991
- Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin, and gentamicinAntimicrobial Agents and Chemotherapy, 1991
- The life and times of the EnterococcusClinical Microbiology Reviews, 1990
- Structure, biochemistry and mechanism of action of glycopeptide antibioticsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalisAntimicrobial Agents and Chemotherapy, 1989
- Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalisAntimicrobial Agents and Chemotherapy, 1989
- Inducible Resistance to Vancomycin in Enterococcus faecium D366The Journal of Infectious Diseases, 1989
- Transferable vancomycin and teicoplanin resistance in Enterococcus faeciumAntimicrobial Agents and Chemotherapy, 1989
- Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus FaeciumNew England Journal of Medicine, 1988
- VANCOMYCIN-RESISTANT ENTEROCOCCIThe Lancet, 1988